KROS
$20.275 +2.174999999999997 (+12.016574585635343%)

Keros Therapeutics, Inc. Stock Statistics

Interactive Statistics Available: Visit the full interactive page to explore detailed statistics, comparative metrics, and historical performance data for KROS.

Valuation Metrics

Price-to-Earnings (P/E) Ratio N/A
Market Capitalization $823.5M
Enterprise Value $146.0M

Trading Statistics

Volume 0
52-Week High $70.00
52-Week Low $9.55

Financial Health

Profit Margin -5277.5%

Dividend Information

Dividend Yield 0.00%%
Payout Ratio -0%
Comprehensive Analysis: The interactive version includes advanced statistics, peer comparisons, technical indicators, and detailed performance analytics.